These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 18057242)
1. Hepatitis A virus mutant spectra under the selective pressure of monoclonal antibodies: codon usage constraints limit capsid variability. Aragonès L; Bosch A; Pintó RM J Virol; 2008 Feb; 82(4):1688-700. PubMed ID: 18057242 [TBL] [Abstract][Full Text] [Related]
2. Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies. Sabrià A; Gregori J; Garcia-Cehic D; Guix S; Pumarola T; Manzanares-Laya S; Caylà JA; Bosch A; Quer J; Pintó RM EBioMedicine; 2019 Jan; 39():348-357. PubMed ID: 30472089 [TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Nainan OV; Brinton MA; Margolis HS Virology; 1992 Dec; 191(2):984-7. PubMed ID: 1280386 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display. Kim SJ; Jang MH; Stapleton JT; Yoon SO; Kim KS; Jeon ES; Hong HJ Virology; 2004 Jan; 318(2):598-607. PubMed ID: 14972527 [TBL] [Abstract][Full Text] [Related]
5. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. Ping LH; Lemon SM J Virol; 1992 Apr; 66(4):2208-16. PubMed ID: 1312628 [TBL] [Abstract][Full Text] [Related]
6. Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane. Sánchez G; Aragonès L; Costafreda MI; Ribes E; Bosch A; Pintó RM J Virol; 2004 Sep; 78(18):9807-13. PubMed ID: 15331714 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak. Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC J Virol; 2018 May; 92(9):. PubMed ID: 29444940 [TBL] [Abstract][Full Text] [Related]
9. Evidence for quasispecies distributions in the human hepatitis A virus genome. Sánchez G; Bosch A; Gómez-Mariano G; Domingo E; Pintó RM Virology; 2003 Oct; 315(1):34-42. PubMed ID: 14592757 [TBL] [Abstract][Full Text] [Related]
10. The Critical Role of Codon Composition on the Translation Efficiency Robustness of the Hepatitis A Virus Capsid. D'Andrea L; Pérez-Rodríguez FJ; de Castellarnau M; Guix S; Ribes E; Quer J; Gregori J; Bosch A; Pintó RM Genome Biol Evol; 2019 Sep; 11(9):2439-2456. PubMed ID: 31290967 [TBL] [Abstract][Full Text] [Related]
11. Antigenic structure of polioviruses of serotypes 1, 2 and 3. Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046 [TBL] [Abstract][Full Text] [Related]
12. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro. Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868 [TBL] [Abstract][Full Text] [Related]
13. Genome variability and capsid structural constraints of hepatitis a virus. Sánchez G; Bosch A; Pintó RM J Virol; 2003 Jan; 77(1):452-9. PubMed ID: 12477850 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids. Costafreda MI; Pérez-Rodriguez FJ; D'Andrea L; Guix S; Ribes E; Bosch A; Pintó RM J Virol; 2014 May; 88(9):5029-41. PubMed ID: 24554668 [TBL] [Abstract][Full Text] [Related]
15. Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines. Su Q; Guo M; Jia Z; Qiu F; Lu X; Gao Y; Meng Q; Tian R; Bi S; Yi Y J Virol Methods; 2016 Jul; 233():41-5. PubMed ID: 26994964 [TBL] [Abstract][Full Text] [Related]
16. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. Borrego B; Novella IS; Giralt E; Andreu D; Domingo E J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417 [TBL] [Abstract][Full Text] [Related]
17. Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli. Yoda T; Terano Y; Suzuki Y; Yamazaki K; Oishi I; Utagawa E; Shimada A; Matsuura S; Nakajima M; Shibata T Microbiol Immunol; 2000; 44(11):905-14. PubMed ID: 11145271 [TBL] [Abstract][Full Text] [Related]
18. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles. Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081 [TBL] [Abstract][Full Text] [Related]
19. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. Taniguchi K; Maloy WL; Nishikawa K; Green KY; Hoshino Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M J Virol; 1988 Jul; 62(7):2421-6. PubMed ID: 2453680 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. Wobus CE; Hügle-Dörr B; Girod A; Petersen G; Hallek M; Kleinschmidt JA J Virol; 2000 Oct; 74(19):9281-93. PubMed ID: 10982375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]